144 related articles for article (PubMed ID: 7538794)
1. Short-term oral treatment of canine benign prostatic hypertrophy with chlormadinone acetate.
Orima H; Shimizu M; Tsutsui T; Kawakami E; Ogasa A
J Vet Med Sci; 1995 Feb; 57(1):139-41. PubMed ID: 7538794
[TBL] [Abstract][Full Text] [Related]
2. Effects of oral administration of chlormadinone acetate on canine prostatic hypertrophy.
Kawakami E; Tsutsui T; Shimizu M; Orima H; Makanae Y; Yajima K; Ogasa A
J Vet Med Sci; 1993 Aug; 55(4):631-5. PubMed ID: 7691191
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of chlormadinone acetate-pellet implantation and orchidectomy on benign prostatic hypertrophy in the dog.
Kawakami E; Tsutsui T; Shimizu M; Orima H; Fujita M; Ogasa A
Int J Androl; 1995 Oct; 18(5):248-55. PubMed ID: 8567095
[TBL] [Abstract][Full Text] [Related]
4. Chlormadinone acetate pellet implantation plus short-term oral administration in dogs with benign prostatic hypertrophy.
Kawakami E; Shimizu M; Orima H; Fujita M; Hori T; Tsutsui T
Int J Androl; 1998 Apr; 21(2):67-73. PubMed ID: 9675615
[TBL] [Abstract][Full Text] [Related]
5. Regression of prostatic hypertrophy by osaterone acetate in dogs.
Tsutsu T; Hori T; Shimizu M; Orima H; Kawakami E; Fukuda S
J Vet Med Sci; 2000 Oct; 62(10):1115-9. PubMed ID: 11073087
[TBL] [Abstract][Full Text] [Related]
6. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H
J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
[TBL] [Abstract][Full Text] [Related]
7. The effects of osaterone acetate on clinical signs and prostate volume in dogs with benign prostatic hyperplasia.
Socha P; Zduńczyk S; Tobolski D; Janowski T
Pol J Vet Sci; 2018 Dec; 21(4):559-566. PubMed ID: 30605276
[TBL] [Abstract][Full Text] [Related]
8. Effect of osaterone acetate administration on prostatic regression rate, peripheral blood hormone levels and semen quality in dogs with benign prostatic hypertrophy.
Tsutsui T; Hori T; Shimizu M; Tatsuzawa C; Kawakami E
J Vet Med Sci; 2001 Apr; 63(4):453-6. PubMed ID: 11346183
[TBL] [Abstract][Full Text] [Related]
9. Effect of antiandrogen, chlormadinone acetate (CMA), in canine spontaneous benign prostatic hyperplasia (BPH).
Murakoshi M; Ikada R; Tagawa M; Nakayama T
Tokai J Exp Clin Med; 2000 Apr; 25(1):11-4. PubMed ID: 11023050
[TBL] [Abstract][Full Text] [Related]
10. Relationship between prostatic atrophy and apoptosis in the canine spontaneous benign prostatic hyperplasia (BPH) following chlormadinone acetate (CMA).
Murakoshi M; Ikeda R; Fukui N; Nakayama T
Tokai J Exp Clin Med; 2001 Jul; 26(2):71-5. PubMed ID: 11806444
[TBL] [Abstract][Full Text] [Related]
11. Effects of a new steroidal aromatase inhibitor, TZA-2237, and/or chlormadinone acetate on hormone-induced and spontaneous canine benign prostatic hyperplasia.
Ito K; Fukabori Y; Shibata Y; Suzuki K; Mieda M; Gotanda K; Honma S; Yamanaka H
Eur J Endocrinol; 2000 Oct; 143(4):543-54. PubMed ID: 11022202
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory influence of a new steroidal anti-androgen, TZP-4238, on prostatic hyperplasia in the beagle dog.
Murakoshi M; Inada R; Tagawa M; Makino M; Suzuki M; Mieda M; Honma S; Takezawa Y; Yamanaka H
Acta Pathol Jpn; 1992 Mar; 42(3):151-7. PubMed ID: 1373927
[TBL] [Abstract][Full Text] [Related]
13. Efficacies of osaterone and delmadinone in the treatment of benign prostatic hyperplasia in dogs.
Albouy M; Sanquer A; Maynard L; Eun HM
Vet Rec; 2008 Aug; 163(6):179-83. PubMed ID: 18689779
[TBL] [Abstract][Full Text] [Related]
14. Effect of chlormadinone acetate-pellet implantation on the volume of prostate, peripheral blood levels of sex hormones and semen quality in the dog.
Shimizu M; Tsutsui T; Kawakami E; Hori T; Fujita M; Orima H; Ogasa A
J Vet Med Sci; 1995 Jun; 57(3):395-9. PubMed ID: 7548388
[TBL] [Abstract][Full Text] [Related]
15. The effects of chlormadinone acetate (CMA), antiandrogen, on the pituitary, testis, prostate and adrenal gland of the dog with spontaneous benign prostatic hyperplasia.
Murakoshi M; Ikeda R; Fukui N
J Toxicol Sci; 2001 Aug; 26(3):119-27. PubMed ID: 11552295
[TBL] [Abstract][Full Text] [Related]
16. Immunolocalization of androgen receptor in canine prostatic hyperplasia--effect of antiandrogen.
Murakoshi M; Ikeda R; Tagawa M; Nakayama T; Honma S; Mieda M
Tokai J Exp Clin Med; 1998 Nov; 23(5):209-12. PubMed ID: 10418722
[TBL] [Abstract][Full Text] [Related]
17. Atrophic effects of antiandrogen, chlormadinone acetate (CMA) on dog prostate with spontaneous benign prostatic hyperplasia.
Murakoshi M; Tagawa M; Ikeda R
J Toxicol Sci; 2000 Aug; 25(3):143-50. PubMed ID: 10987120
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of the long-term treatment with chlormadinone acetate in patients with benign prostatic hypertrophy].
Kogawa T; Yanagiya H; Takashima T; Higashino I; Kudo T; Suzuki T; Mikuni T; Kido K; Tsukui A; Yagihashi Y
Hinyokika Kiyo; 1993 Mar; 39(3):281-7. PubMed ID: 7685143
[TBL] [Abstract][Full Text] [Related]
19. Histological evaluation of benign prostatic hyperplasia treated by long-term administration of chlormadinone acetate (CMA).
Harada M; Kinoshita Y; Moriyama M; Kondo I; Nakahashi M; Kumagai H; Sasaki K; Hosaka M
Prostate; 1994 Sep; 25(3):147-55. PubMed ID: 7520578
[TBL] [Abstract][Full Text] [Related]
20. Effects of a new steroidal antiandrogen, TZP-4238 (17 alpha-acetoxy-6-chloro-2-oxa-4, 6-pregnadiene-3, 20-dione), on spontaneously developed canine benign prostatic hyperplasia.
Takezawa Y; Ito K; Suzuki K; Fukabori Y; Yamanaka H; Honma S; Mieda M; Hamataki N; Kushitani M
Prostate; 1995 Dec; 27(6):321-8. PubMed ID: 7501544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]